SCHEMBL31666083

SCHEMBL31666083

O=C(O)c1c2c(nc3ccccc13)CCN(CCc1ccccc1)C2

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.56
▸ MAPK1 P28482 2/20 0.56
▸ TP53 P04637 1/20 0.56
▸ KMT2A Q03164 2/20 0.54
▸ MEN1 O00255 1/20 0.54
▸ MAPT P10636 3/20 0.53
▸ POLB P06746 2/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ HTT P42858 2/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ RAB9A P51151 1/20 0.51
▸ LMNA P02545 4/20 0.50
▸ KDM4E B2RXH2 2/20 0.50
▸ NPSR1 Q6W5P4 1/20 0.50
▸ TDP1 Q9NUW8 1/20 0.50
▸ PTPN2 P17706 1/20 0.47
▸ PTPN1 P18031 1/20 0.47
▸ GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26098455 1.00 ALDH1A1 (0.56) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL31666079 0.88 ALDH1A1 (0.48) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL26098464 0.88 ALDH1A1 (0.48) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL12301081 0.88 KMT2A (0.70) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL26454719 0.88 ALDH1A1 (0.62) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL26100476 0.87 TDP1 (0.56) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL31666080 0.87 TDP1 (0.56) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL26454732 0.87 MAPT (0.68) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL26099431 0.84 MAPT (0.70) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL26098359 0.81 MAPT (0.60) ALDH1A1MAPK1TP53KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12370183-B2 Compositions and methods for treating malaria RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 2025-07-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12370183-B2 Compositions and methods for treating malaria G6PD, QDPR, FASN ALDH1A1 1569/4885MAPK1 4097/4885TP53 4568/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback